About Fermiscan Limited

Fermiscan is working to develop a world-first innovative test for the detection of breast cancer using hair. The breakthrough technology that underpins the Fermiscan™ Test is the discovery by an Australian scientist that breast cancer can potentially be detected by synchrotron x-ray diffraction of hair. The test is non-invasive and suitable for women from as early as 20 years of age. It may provide early detection of breast cancer thus assist in early treatment. Early detection benefits range from increased survival, increased treatment options and improved quality of life. The Fermiscan™ Test is in trial and not yet available commercially.

Annual and Investor Reports

Annual Report

09-05-08

Chairman's Address PDF Click here to download

09-05-08

Managing Directors Report PDF Click here to download

28-03-08

Annual Report 2007 PDF Click here to download

30-03-07

Annual Report 2006 PDF Click here to download

 

Investor Report

18-06-08

Investor Presentation June 2008 PDF Click here to download

09-01-08

Australian Financial Review 5 - 6 January 2008 PDF Click here to download

 

Media

01-08-08

Readers Digest August 2008 PDF Click here to download

 

20-06-08

National NBC TV News interview with David Young Fermiscan Managing Director
Click here to view


18-06-08

Announcement from the Minister for Science and Medical Research, the Hon. Verity Firth at Bio 2008, USA PDF Click here to download


24-01-08

Innovation Day Shoot Out Competition Announcement
Sky News (Australia)


24-01-08

Interview with David Young - Fermiscan managing director.
Business Morning Fox Business (USA) Click here to view